Latest Insider Transactions at Lineage Cell Therapeutics, Inc. (LCTX)
This section provides a real-time view of insider transactions for Lineage Cell Therapeutics, Inc. (LCTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lineage Cell Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lineage Cell Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Neal C Bradsher Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,720
+22.0%
|
$49,440
$2.2 P/Share
|
|
Jun 22
2021
|
Alfred D Kingsley Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
61,800
+1.12%
|
$123,600
$2.2 P/Share
|
|
Jun 18
2021
|
Michael H. Mulroy |
BUY
Exercise of conversion of derivative security
|
Direct |
24,720
+8.95%
|
$49,440
$2.2 P/Share
|
|
Mar 31
2021
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,343
-2.66%
|
$10,686
$2.35 P/Share
|
|
Mar 31
2021
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,450
+7.14%
|
$30,900
$2.35 P/Share
|
|
Mar 30
2021
|
Alexandra Hernandez Sr Director Finance/Controller |
SELL
Open market or private sale
|
Direct |
6,000
-100.0%
|
$12,000
$2.23 P/Share
|
|
Mar 30
2021
|
Alexandra Hernandez Sr Director Finance/Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$0
$0.69 P/Share
|
|
Dec 31
2020
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,343
-2.8%
|
$5,343
$1.76 P/Share
|
|
Dec 31
2020
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,450
+7.49%
|
$15,450
$1.76 P/Share
|
|
Sep 30
2020
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,343
-2.95%
|
$0
$0.94 P/Share
|
|
Sep 30
2020
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,450
+7.87%
|
$0
$0.94 P/Share
|
|
Aug 15
2019
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 15
2019
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
13,146
+0.04%
|
$0
$0.97 P/Share
|
|
Aug 14
2019
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 14
2019
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
1,407
+0.0%
|
$0
$0.98 P/Share
|
|
Aug 13
2019
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 13
2019
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.03%
|
$0
$0.99 P/Share
|
|
Apr 16
2019
|
Broadwood Partners, L.P. Director |
BUY
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Apr 16
2019
|
Broadwood Partners, L.P. Director |
BUY
Other acquisition or disposition
|
Direct |
251,835
+0.74%
|
$251,835
$1.32 P/Share
|
|
Mar 08
2019
|
Broadwood Partners, L.P. Director |
BUY
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Mar 08
2019
|
Broadwood Partners, L.P. Director |
BUY
Other acquisition or disposition
|
Direct |
3,757,430
+10.02%
|
-
|
|
Oct 13
2017
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Oct 13
2017
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
2,692,307
+8.24%
|
$5,384,614
$2.6 P/Share
|
|
Aug 22
2017
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 22
2017
|
Broadwood Partners, L.P. Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.04%
|
$20,000
$2.6 P/Share
|